Released: October 30, 2020 Expires: October 30, 2021 Jointly Accredited by the Consortium of Multiple Sclerosis Centers (CMSC) and Haymarket Medical Education (HME). Supported by an educational grant from Bristol Myers Squibb. Intended Audience Neurologists and other physicians, nurse practitioners, PAs, registered nurses, and pharmacists who collaborate to provide care for patients with MS Program …
Continue reading “Next-Generation S1P Modulators in MS Management”
Thursday, November 12, 2020 8:00 pm EST Learning Objectives Define symptoms of NMOSD and common diseases that mimic NMOSD Summarize consensus diagnostic criteria for NMOSD Review diagnostic testing methods for NMOSD Employ team-based approaches to the early and accurate diagnosis of NMOSD Review novel treatment options for NMOSD Apply evidence-based approaches to personalizing treatment for …
RELEASE DATE: October 21, 2020 VALID FOR CREDIT THROUGH: October 21, 2021 This activity is jointly provided by The Consortium of Multiple Sclerosis Centers (CMSC) and CMEology. This activity is supported by educational grants from Biogen, Bristol Myers Squibb, and EMD Serono. Target Audience This activity is designed to meet the educational needs of neurologists, …
Release Date: October 20, 2020 Valid for Credit Through: October 31, 2021 Target Audience The target audience for this activity is nursing professionals involved in the management of patients with MS. Learning Objectives At the conclusion of this activity, learners should be better able to: Incorporate accumulated evidence, current guidelines, and emerging new clinical data …
Continue reading “Differing Perspectives on Multiple Sclerosis Nursing Care”
Release Date: July 31, 2020 Valid for Credit Through: July 31, 2021 Provided by The Consortium of Multiple Sclerosis Centers and Catamount Medical Education. This activity is supported in part by independent education grants from Alexion Pharmaceuticals and Genentech. Credit Available Physicians — maximum of 1.25 AMA PRA Category 1 Credit(s)™ Nurses — 1.25 Nursing Contact Hours Pharmacists — 1.25 Contact …
Reshaping the Paradigm: Implications of Recent Clinical Advances in the Diagnosis and Treatment of Neuromyelitis Optica Spectrum Disorder (NMOSD) — An ACTRIMS-ECTRIMS Virtual Satellite Release Date: 10/07/2020 Valid for Credit through: 10/07/2021 Overview This case-based activity, originally held as a satellite symposium in conjunction with MSVirtual2020, is designed to present several key analytic and diagnostic …
Release Date: October 1, 2020 Valid for Credit Through: October 1, 2021 Comparing Health Promotion and Quality of Life in People with Progressive Versus Nonprogressive Multiple Sclerosis Wenhui Zhang, PhD, MS, RN; Heather Becker, PhD; Alexa Stuifbergen, PhD, RN, FAAN Target Audience The target audience for this activity is physicians, physician assistants, nursing professionals, and …
RELEASE DATE: October 1, 2020 EXPIRATION DATE: September 30, 2021 The Iceberg Effect: Subclinical Disease Activity in Multiple Sclerosis Continuing Education Supplement to the International Journal of MS Care ACKNOWLEDGEMENT This activity is supported by an educational grant from Genentech. TUITION Complimentary GENERAL CME/CNE/CPE INFORMATION In order to successfully complete this continuing education activity, the participant …
Continue reading “The Iceberg Effect: Subclinical Disease Activity in Multiple Sclerosis”
CANNABIS AND MS: HELPING PATIENTS UNDERSTAND RISKS AND BENEFITS SESSION 2: CANNABIS AS AN HERBAL MEDICINE – EFFICACY/SIDE EFFECT CONSIDERATIONS AND CASE STUDIES OCTOBER 21, 2020 7:00 – 8:00 pm ET SERIES DESCRIPTION MS health professionals may be involved in the decision-making process about cannabis and provide care to those with MS who use cannabis. …
CANNABIS AND MS: HELPING PATIENTS UNDERSTAND RISKS AND BENEFITS SESSION 3: PHARMACOLOGY AND INTERACTIONS, TRIAL DATA, DMTs, AND CASE STUDIES OCTOBER 28, 2020 7:00 – 8:00 pm ET SERIES DESCRIPTION MS health professionals may be involved in the decision-making process about cannabis and provide care to those with MS who use cannabis. However, numerous surveys …